arrow
H

Hongjun Liu

henan university
H指数:23
被引数:2,231

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine–oxaliplatin versus short-course radiotherapy followed by capecitabine–oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial

短程放疗联合新辅助治疗后给予西宁利珠单抗联合卡培他滨–奥沙利铂 versus 短程放疗后给予卡培他滨–奥沙利铂用于局部晚期直肠癌患者的治疗方案(SPRING-01):一项单中心、开放标签、Ⅱ期、随机对照试验

2025-07-080
PRE
Outcomes of Children and Adolescents with Acute Myeloid Leukemia and KIT Mutations Treated with Low- or Standard-Dose Chemotherapy Plus Dasatinib on the CALSIII-AML18 Trial

CALSIII-AML18试验中,携带KIT突变且接受低剂量或标准剂量化疗联合达沙替尼治疗的儿童和青少年急性髓系白血病患者的结局

BLOOD
IF23.1
2024-11-050
PRE
Outcomes of Children and Adolescents with Acute Myeloid Leukemia and FLT3-ITD Treated with Low- or Standard-Dose Chemotherapy Plus Sorafenib on the Cals III-AML18 Trial (ChiCTR1800015883)

急性髓系白血病伴FLT3-ITD的儿童和青少年接受低剂量或标准剂量化疗联合索拉非尼治疗在Cals III-AML18试验(ChiCTR1800015883)中的结局

BLOOD
IF23.1
2024-11-050
PRE
Constructing Atomic Fe and N Co-doped Hollow Carbon Nanospheres with a Polymer Encapsulation Strategy for High-Performance Lithium-Sulfur Batteries with Accelerated Polysulfide Conversion

用聚合物封装策略构建原子Fe和N共掺杂的中空碳纳米球,用于具有加速的多硫化物转化的高性能锂硫电池

2022-04-216
PRE